AtlasXomics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14M

  • Investors
  • 7

AtlasXomics General Information

Description

Developer of a spatial epigenome technology platform designed to provide multi-omics tissue atlases. The company's platform leverages microfluidics and next-generation sequencing to create transformative multi-omic maps of proteomics, transcriptomics, and epigenomics in tissue at cellular resolution, enabling clinicians and researchers to unlock information about interactions between cells in localized neighborhoods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 College Street
  • Suite 210
  • New Haven, CT 06510
  • United States
+1 (917)
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 101 College Street
  • Suite 210
  • New Haven, CT 06510
  • United States
+1 (917)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AtlasXomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) 25-Jul-2024 $14M Completed Generating Revenue
4. Grant 16-Sep-2022 Completed Generating Revenue
3. Grant 01-May-2022 Completed Generating Revenue
2. Seed Round 09-Mar-2021 $2.26M $2.26M Completed Startup
1. University Spin-Out 01-Jan-2020 Completed Startup
To view AtlasXomics’s complete valuation and funding history, request access »

AtlasXomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-2
Seed-1 1,461,538 $0.001000 6% $0.68 $0.68 1x $0.68 11.1%
To view AtlasXomics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AtlasXomics Patents

AtlasXomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250146915-A1 System for clamping and aligning a fluidic chip to a tissue section Pending 06-Jun-2023
EP-4601792-A2 Chiplet production and methods of use Pending 21-Nov-2022
US-20260199893-A1 Chiplet production and methods of use Pending 21-Nov-2022
WO-2024112645-A2 Chiplet production and methods of use Inactive 21-Nov-2022
WO-2024112645-A3 Chiplet production and methods of use Inactive 21-Nov-2022 B01L3/502707
To view AtlasXomics’s complete patent history, request access »

AtlasXomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AtlasXomics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Broadfield Capital PE/Buyout Minority
Connecticut Innovations Venture Capital Minority
Spring Mountain Capital Growth/Expansion Minority
U.S. Department of Health and Human Services Government
National Institutes of Health Government
You’re viewing 5 of 7 investors. Get the full list »

AtlasXomics FAQs

  • When was AtlasXomics founded?

    AtlasXomics was founded in 2020.

  • Where is AtlasXomics headquartered?

    AtlasXomics is headquartered in New Haven, CT.

  • What is the size of AtlasXomics?

    AtlasXomics has 22 total employees.

  • What industry is AtlasXomics in?

    AtlasXomics’s primary industry is Discovery Tools (Healthcare).

  • Is AtlasXomics a private or public company?

    AtlasXomics is a Private company.

  • What is the current valuation of AtlasXomics?

    The current valuation of AtlasXomics is .

  • What is AtlasXomics’s current revenue?

    The current revenue for AtlasXomics is .

  • How much funding has AtlasXomics raised over time?

    AtlasXomics has raised $16.3M.

  • Who are AtlasXomics’s investors?

    Broadfield Capital, Connecticut Innovations, Spring Mountain Capital, U.S. Department of Health and Human Services, and National Institutes of Health are 5 of 7 investors who have invested in AtlasXomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process